Navigation Links
Cellceutix Cancer Drug Kevetrin™ Shows No Genotoxicity in Study
Date:3/2/2011

he Company plans to file an Investigational New Drug (IND) application with the U.S. Food and Drug Administration in May 2011 with human trials to begin thereafter.

About Cellceutix

Cellceutix Corporation is a preclinical cancer, anti-inflammatory and autism drug developer. Cellceutix owns the rights to eight drug compounds, including Kevetrin, which it is developing as a treatment for certain cancers, KM-133, for the treatment of psoriasis, and KM-391, for the treatment of autism. More information is available on the Cellceutix web site at www.cellceutix.com.

This Press Release contains forward-looking statements that are based on our current expectations, beliefs and assumptions about the industry and markets in which Cellceutix Corporation operates. Such forward-looking statements involve known and unknown risks, uncertainties, and other factors that may cause Cellceutix's actual results to be materially different from any future results expressed or implied by these statements. Actual results may differ materially from what is expressed in these statements, and no assurance can be given that Cellceutix can successfully implement its core business strategy and improve future earnings.

The factors that may cause Cellceutix's actual results to differ from its forward-looking statements include: Cellceutix's current critical need for additional cash to sustain existing operations and meet ongoing existing obligations and capital requirements; Cellceutix's ability to implement its new product development and commercialization, enter into clinical trials, expand the intellectual property portfolio, and receive regulatory approvals in a timely and cost-effective manner. All forward-looking statements are also expressly qualified in their entirety by the cautionary statements included in Cellceutix's SEC filings, including its quarterly reports on Form 10-Q and
'/>"/>

SOURCE Cellceutix Corporation
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
4. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
5. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
6. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
7. Novel Technology Breaks Through Cancer Pain
8. CEL-SCI Secures Manufacturing Facility for Multikine Cancer Drug
9. Furamidine Found to Inhibit a Key Enzyme Involved in Cancer Cell DNA Repair Mechanisms
10. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
11. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... TARRYTOWN, N.Y. , May 23, 2013 /PRNewswire/ ... reconstruction following mastectomy is an appropriate option ... mutations seeking to surgically reduce their breast cancer ... involves a gradual expansion process and a second ... of implants in the same surgery as mastectomy ...
(Date:5/23/2013)... -- Net Medical Xpress Solutions, Inc., (OTC QB: NMXS), a ... has signed a letter of intent to acquire MedTel ... Huntsville, AL . MedTel Solutions is a physician ... of telemedicine physicians. Consideration for the acquisition will be ... expected by June 30, 2013. Dick Govatski, ...
(Date:5/23/2013)... AVIV, Israel , May 23, 2013 ... BrainTech Israel 2013 , Israel,s ... place on October 14 th -15 th in ... nd most innovative city in the world by the ... "Start-up Nation." BrainTech Israel 2013 will showcase the ...
Breaking Medicine Technology:Direct to Implant ("One Step") Mastectomy Breast Reconstruction Reduces Number of Surgeries and Time to Final Cosmetic Results 2Direct to Implant ("One Step") Mastectomy Breast Reconstruction Reduces Number of Surgeries and Time to Final Cosmetic Results 3Net Medical Xpress Announces Acquisition of Telemedicine Staffing Company 2Net Medical Xpress Announces Acquisition of Telemedicine Staffing Company 3Israel Brain Technologies Announces Israel's 1st International Brain Technology Conference 2Israel Brain Technologies Announces Israel's 1st International Brain Technology Conference 3
... Stem Cell Sciences From University of Cambridge ... - ("Stem Cell Sciences", "SCS", "the Company"), ... STEM, ASX: STC), a company focused on the commercialisation ... paper describing a technique,for reprogramming adult mammalian cells into ...
... Sourced from China Shows Strong Results Presented at ... Cambridge Healthtech Institute Fall Conference, BOSTON, ... Bioscience International (HUYA) today described the,preclinical profile and outcome ... China by Chipscreen Biosciences, Ltd. of Shenzhen. The,clinical trial ...
Cached Medicine Technology:Technique for Rapidly Reprogramming Adult Cells Into Stem Cells Published in PLoS Biology 2Technique for Rapidly Reprogramming Adult Cells Into Stem Cells Published in PLoS Biology 3Chipscreen Biosciences and HUYA Bioscience Int'l Announce Promising Preclincial and Phase I Solid Tumor/Lymphoma Data for Chidamide/HBI-8000, New HDAC Inhibitor for Cancer 2Chipscreen Biosciences and HUYA Bioscience Int'l Announce Promising Preclincial and Phase I Solid Tumor/Lymphoma Data for Chidamide/HBI-8000, New HDAC Inhibitor for Cancer 3Chipscreen Biosciences and HUYA Bioscience Int'l Announce Promising Preclincial and Phase I Solid Tumor/Lymphoma Data for Chidamide/HBI-8000, New HDAC Inhibitor for Cancer 4Chipscreen Biosciences and HUYA Bioscience Int'l Announce Promising Preclincial and Phase I Solid Tumor/Lymphoma Data for Chidamide/HBI-8000, New HDAC Inhibitor for Cancer 5
(Date:5/23/2013)... May 23, 2013 Sika Sarnafil ... waterproofing membranes, today announced Imperial Roof Systems of Iowa ... professionalism and dedication to quality during the re-roofing of ... Systems is a Sika Sarnafil Elite contractor and one ... Roof Systems is committed to sustainable building practices and ...
(Date:5/23/2013)... Washington, DC (PRWEB) May 23, 2013 ... by JD Media Surge, LLC. Targeting members of the ... services online and attract new patients, the consulting service ... Internet marketing strategies. , The medical Internet marketing agency ... struggling to get results online. As part of the ...
(Date:5/23/2013)... Retül University , the market leader ... formation of a strategic educational partnership with Ero ... a bike industry first “Positioned for Speed” course combining ... trial, road and triathlon bike fit. , This course ... with a Retül University, F.I.S.T. or S.I.C.I fit certification. ...
(Date:5/23/2013)... Rapids, IA (PRWEB) May 23, 2013 Diversity ... Creative Corridor have an expanded understanding of diversity. The ... The survey was done from February-March of this year. 1198 ... survey as a follow up to its benchmark survey in ... top factors reported in the definition of diversity were race ...
(Date:5/23/2013)... By Dennis Thompson HealthDay Reporter , , THURSDAY, ... taken by millions to lower their cholesterol, but the ... their cardiovascular health through exercise, researchers say. A ... to make any significant fitness gains while taking a ... not on the drug but undergoing the same exercise ...
Breaking Medicine News(10 mins):Health News:Sika Sarnafil Announces Recycling Project of the Year Winner 2Health News:Healthcare Internet Marketing Consulting Services Launched by JD Media Surge 2Health News:Retül, Ero Sports and Alphamantis Partner for Industry First Aero Fit Course 2Health News:Retül, Ero Sports and Alphamantis Partner for Industry First Aero Fit Course 3Health News:Diversity Focus Announces Results from the 2013 Creative Corridor Community Survey 2Health News:Statins May Hamper Workout Results 2Health News:Statins May Hamper Workout Results 3
... , , WASHINGTON, Aug. 24 In response ... and Cardiovascular H ealth: A Scienti f ic State m ... journal Circulat i on, Dr. Maureen Storey, senior vice ... for t h e America n Beverage A ...
... , Proposed Medicare Cuts Will Harm Seniors, Care, Place ... Jeopardy , , Study Finds California Seniors Hit ... Calif., Aug. 24 A new American Health Care Association analysis of ... recently-enacted Medicare regulation cutting Medicare-funded nursing home care by $12 billion over ...
... RESEARCH TRIANGLE PARK, N.C., Aug. 24 GlaxoSmithKline ... of Advair Diskus(R) (fluticasone propionate and salmeterol inhalation powder) medication ... near Richmond, Virginia. Medicine in the stolen cartons could ... the legitimate supply chain and the storage conditions under which ...
... , NASHVILLE, Tenn., Aug. 24 Cumberland ... it will report second quarter 2009 financial results before the market ... live Internet webcast will be held on Thursday, August 27, 2009 ... , To participate on the call, please dial 877-604-9672 ...
... , , , - ... flawed document he says "pushes pulling the plug." , ... of the national non-profit organization Aging with Dignity, today called on ... "Your Life, Your Choices" advance care planning guide dubbed "The Death ...
... down the disease, study says , MONDAY, Aug. 24 ... very early stages of Alzheimer,s disease might become hyperactive ... , Researchers from the Cleveland Clinic tested 69 mentally ... Alzheimer,s disease because of family history or genetic markers. ...
Cached Medicine News:Health News:American Beverage Association Response to American Heart Association Statement on Added Sugars 2Health News:New Study of House Health Reform Bill: California Faces Over $3.7 Billion in Medicare-Funded Nursing Home Cuts Over Ten Years 2Health News:GSK Advisory: Warehouse Theft 2Health News:Cumberland Pharmaceuticals to Announce Second Quarter 2009 Financial Results on August 27, 2009 2Health News:Veterans Administration Must Suspend Use of So-Called 'Death Book' on Veterans, Malley Says 2Health News:MRI Might Find Early Alzheimer's 2
... the Marco Keratometer I and ... instruments for objectively measuring corneal ... the added feature of internal ... or those who prefer to ...
... been selling replacement bulbs on ... we are extremely proud of ... out our catalog of replacement ... light bulbs specials. ,Check ...
... Bulb Direct has been selling ... since 1996, and we are ... satisfaction guarantee. Check out our ... see our discount light bulbs ...
... been selling replacement bulbs on ... we are extremely proud of ... out our catalog of replacement ... light bulbs specials. ,Check ...
Medicine Products: